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Abstract National-scale health impact assessments (HIAs)
have been conducted for many years and have become
reasonably systematized. Recently, there has been growing
interest in utilizing HIA methods at local scales, in the
context of Environmental Public Health Tracking and in
other settings. This paper investigates the data and
analytical challenges to estimating the incidence of health
effects associated with changes in air pollution concen-
trations at the local scale, focusing on ozone and fine
particulate matter. Although it could be argued that the
local-scale HIA is simply a more geographically discrete
version of the national-scale assessment and, therefore, has
similar challenges, in practice, many key inputs in national-
scale assessments are assumed to be spatially uniform or
vary only at coarse geographic resolution. For a national-
scale assessment, this assumption may not contribute
appreciable bias, but the bias could be significant for any
individual location. Thus, local-scale assessments require
more geographically resolved air quality data, concentration–
response (C-R) functions, and baseline incidence rates than
are often used. However, comprehensive local data may not
be available, may be incomplete, or may be time-intensive
and resource-intensive to develop, especially for C-R
functions for which small-scale epidemiological studies
will often be underpowered. Given this context, this paper
considers how best to develop credible local-scale HIAs,
identifying factors that contribute to variability across
geographic areas, study designs, and time periods. This
paper also describes which key sources of analytical
uncertainty change as the scope shifts from the national
to the local scale. These challenges notwithstanding, the
paper concludes that a well-designed local-scale HIA,
following key principles and recommendations, can be
both informative and defensible.
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Introduction
In the United States (U.S.), regulatory agencies such as the
U.S. Environmental Protection Agency (EPA) have an
extensive history of performing national-scale health
benefits assessments of major air pollution regulations. In
one such analysis, the U.S. EPA estimated that implemen-
tation of the Clean Air Act amendments would result in
approximately 23,000 premature deaths avoided in 2010,
relative to a baseline of Clean Air Act implementation
without the amendments (U.S. EPA 1999). More recently,
EPA has systematized this approach by developing the
Environmental Benefits Mapping and Analysis Program
(BenMAP) for estimating national-scale health benefits of
policies and regulations to reduce air pollution. BenMAP
was used in recent Regulatory Impact Analyses (RIAs)
of the Clean Air Interstate Rule and Nonroad Diesel Rule
(U.S. EPA 2004, 2005), finding that, when fully imple-
mented, those two rules combined would result in close to
30,000 premature deaths from air pollution avoided annually.
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The general approach utilized within these analyses has been
found to be reasonable and informative for policy decision-
making in spite of inherent uncertainties (NRC 2002).
In recent years, interest has grown among both regula-
tory agencies and researchers in developing similar types of
assessments at subnational or local scales, focusing on
either the health impacts of pollutants or the health benefits
of control strategies. For example, while the RIA of the
Clean Air Interstate Rule (U.S. EPA 2005) estimated air
quality changes at 36 km resolution and provided health
benefits estimates only at the national scale, other studies
have used atmospheric models with census tract resolution
and provided health benefits estimates for individual tracts
or as a function of distance from individual sources (Levy
and Spengler 2002; Levy et al. 2002). In addition, BenMAP
analyses have been conducted to address a variety of risk
management questions in Philadelphia, Detroit, California,
Georgia, and for the LakeMichigan Air Directors Consortium
(Chang et al. 2007; Cohan et al. 2007; Clean Air Council
2004; Deck 2006; U.S. EPA 2007a).
A local-scale health impact assessment (HIA; considered
henceforth to be urban-scale) applies essentially identical
methods as a national-scale HIA, but is distinguished by the
heightened importance of spatially refined input data. In
principle, a national-scale assessment would rely on the
same spatially varying input data as used in a local-scale
assessment. However, in practice, many key inputs are
assumed to be spatially uniform or to vary only across
regions of the country. For a national-scale assessment
focused on total national impacts, this may not contribute
appreciable bias, but the bias may be larger for individual
urban areas.
As a result, there are multiple tensions and tradeoffs that
analysts must weigh in attempting to construct defensible
local-scale HIAs. In general, as the spatial scale decreases,
national or “generic” data may become less representative.
At the same time, local data may not be available or may be
more uncertain given smaller sample sizes. In addition,
there is a tension between developing assessments that are
locally meaningful and using methods that are consistent
with other HIAs, so that results can be compared across
settings. Finally, if HIAs are to be conducted on a regular
basis, the HIA methodology should provide a mechanism
for collection and use of regularly updated data and
concentration–response (C-R) functions.
This paper explores each of these issues in the context of
ozone and fine particulate matter (PM2.5) HIAs in the U.S.
Historically, these are the two pollutants that dominate the
health benefits of air pollution control strategies. As a
result, ozone and PM2.5 were selected within the Environ-
mental Public Health Tracking (EPHT) program framework
as key pollutants to evaluate within a local-scale HIA
context (CDC 2007). In the “Overview of health impact
assessment methods” section, we provide a brief conceptual
overview of HIA methods. In the “Analytical challenges to
performing a local-scale HIA” section, we discuss critical
data issues that must be addressed when conducting a local-
scale HIA. In the “Consideration of time-varying factors in
conducting local-scale health impact assessments over
time” section, we discuss the need to consider the influence
of time-varying factors in conducting local-scale HIAs over
time. In the “Characterizing uncertainty in local-scale health
impact assessments” section, we discuss characterization of
uncertainty, including aspects that are amplified at the local
scale. Finally, in the “Conclusions and recommendations”
section, we conclude with some recommendations for the
conduct of local-scale HIAs.
Overview of health impact assessment methods
The key elements of health impact assessments (HIAs) are
illustrated in Fig. 1, and include:
1. Estimate a change in or increment of ambient air
quality, using monitoring data (from ground-based or
satellite measurements), modeled air quality, or a
combination of the two. These air quality changes
may be actual or hypothetical.
2. Combine air quality changes with population informa-
tion to determine changes in population exposure in a
form that is relevant given the epidemiological evi-
dence (e.g., the appropriate averaging time).
3. Combine changes in population exposure to ambient air
pollution with impact functions1 to generate distribu-
tions of changes in the incidence of health effects. The
impact functions are constructed using population data,
baseline health effect incidence and prevalence rates,
and C-R functions.
4. Characterize the results of the HIA, through the use of
summary statistics (e.g., mean, 95% confidence interval),
graphs (e.g., cumulative distribution functions and box-
plots), and maps.
Health impact functions estimate the change in a health
endpoint of interest, such as hospital admissions, for a
1 The term “impact function” as used here refers to the combination of
(a) a C-R function obtained from the epidemiological literature, (b) the
baseline incidence for the health effect of interest in the modeled
population, and (c) the size of that modeled population. The impact
function is distinct from the C-R function, which strictly refers to the
estimated equation from the epidemiological study relating the relative
risk of the health effect and ambient pollution. We refer to the specific
value of the relative risk or estimated coefficients in the epidemiolog-
ical study as the “C-R function.” In referencing the functions used to
generate changes in incidence of health effects for this paper, we use
the term “impact function.”
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given change in air pollution concentrations (here, consid-
ered to be either ambient ozone or PM2.5). A typical health
impact function might look like:
Δy ¼ y0  ebΔx  1
 
where y0 is the baseline incidence (the product of the
baseline incidence rate times the potentially affected
population), β is the C-R function, and Δx is the estimated
change in ambient concentrations. There are other func-
tional forms, but the basic elements remain the same.
Identifying health outcomes of interest
An important initial step in an HIA (whether national-scale
or local-scale) is to consider which health outcomes to
include in the analysis. Several types of data can support
this determination, including toxicological studies (animal
and cellular studies), human clinical studies, and observa-
tional epidemiology studies. All of these data sources
provide important contributions to the weight of evidence
regarding the biological plausibility of a particular health
outcome; however, only epidemiological studies provide
direct C-R functions which can be used to evaluate
population-level impacts of reductions in ambient levels
of criteria air pollutants such as ozone and PM2.5. The
selection of a health outcome, therefore, follows a weight of
evidence approach, based on the biological plausibility of
effects, availability of C-R functions from well-conducted
peer-reviewed epidemiological studies, cohesiveness of
results across studies, and a focus on endpoints reflecting
public health impacts (like hospital admissions) rather than
physiological responses (such as forced expiratory volume
in 1 s [FEV1]). Table 1 lists some of the health endpoints
included in recent HIAs for ozone and PM2.5.
The quantitative aspect of HIA, therefore, relies on the
outputs from environmental epidemiology. A downside is
that standard epidemiological studies provide only a limited
representation of the uncertainty associated with a specific
C-R function, measuring only the statistical error in the
estimates, usually relating to the power of the underlying
study (driven largely by population size and the frequency
of the outcome measure). There are other sources of
uncertainty in the relationships between ambient pollution
and population-level health outcomes, including model
specification, potential confounding by factors that are both
correlated with the health outcome and each other, and
other factors such as exposure misclassification. Other
study designs may provide insight about these issues but
Table 1 Health endpoints included in recent U.S. EPA national-scale
HIAs (U.S. EPA 2005, 2006)
Health endpoint PM2.5 Ozone
Mortality ✓ ✓
Chronic bronchitis ✓
Nonfatal heart attacks ✓
Hospital admissions ✓ ✓
Asthma ER visits ✓ ✓
Minor restricted activity days ✓ ✓
Asthma attacks ✓ ✓
Work loss days ✓
Worker productivity ✓
School absence rates ✓
Fig. 1 HIA—analytical
framework
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are difficult to capture quantitatively. For example, expert
elicitation methods have been used to integrate across
various sources of data in developing C-R functions for RIAs,
a topic discussed in greater detail in the “Characterizing
uncertainty in local-scale health impact assessments” section.
Selecting C-R functions
For health outcomes for which multiple studies are
available, criteria need to be developed to determine which
studies are likely to provide the best C-R functions given
the context of the HIA, as well as how the estimates from
these studies should be weighted and combined. These
criteria may include consideration of whether the study was
peer-reviewed, the match between the pollutant studied and
the pollutant of interest, whether potential co-pollutant
confounding was addressed, the study design and location,
and characteristics of the study population, among other
considerations. To account for the potential impacts of
different health care systems or underlying health status of
populations, it may make sense to give preference to studies
conducted in the country of interest, although the relative
importance of country-specific characteristics may vary by
health outcome (with health care utilization measures likely
depending more on country characteristics than disease
development).
Table 2 is a summary table from the ozone National
Ambient Air Quality Standards (NAAQS) RIA (U.S. EPA
2007b) which demonstrates some of the issues confronted
in selecting and applying C-R functions in a national-scale
analysis. First, EPA relied on multicity studies or meta-
analyses of the mortality literature rather than selecting
epidemiological studies conducted in individual cities, but
did not attempt to formally combine the evidence across
these studies. The individual row estimates for mortality,
therefore, reflect the variability in the C-R functions for
ozone mortality across these studies. Ranges within each
column reflect the uncertainty in the ozone C-R functions
as well as in the estimates of PM2.5 premature mortality
impacts across the available C-R functions for PM2.5
mortality. Similar characterization could be conducted for
morbidity outcomes as well, although the existence of
fewer studies makes it more difficult to encapsulate
uncertainty as fully.
Estimating baseline incidence
Given the C-R functions for various health outcomes, the
remainder of the impact function depends on the baseline
incidence rate and the size of the relevant exposed
population. The way in which the health outcome is
defined should be in agreement with the epidemiological
studies underlying the C-R function. Some epidemiological
studies examine the association between pollution levels
and adverse health effects in a specific subpopulation, such
as asthmatics or diabetics. In these cases, it is necessary to
Table 2 Summary of 2020 national health impacts associated with attainment strategies for alternative ozone NAAQS (U.S. EPA 2007a)
Standard alternative and model or assumption Combined range of ozone benefits and PM2.5 co-benefits
0.079ppm 0.075ppm 0.070ppm 0.065ppm
Combined estimate of mortality
NMMAPS Bell et al. (2004) 200 to 1,900 430 to 2,600 670 to 4,300 1,200 to 7,400
Bell et al. (2005) 260 to 2,000 1,100 to 3,300 1,500 to 5,100 2,800 to 9,000
Meta-analysis Ito et al. (2005) 270 to 2,000 1,200 to 3,300 1,600 to 5,200 3,000 to 9,200
Levy et al. (2005) 260 to 2,000 1,300 3,500 1,800 to 5,400 3,000 to 9,200
No causality 180 to 1,900 230 to 2,400 390 to 4,000 660 to 6,900
Combined estimate of morbidity
Acute myocardial infarction 1,100 1,400 2,300 4,000
Hospital and ER visits 1,300 5,600 7,600 13,000
Chronic bronchitis 370 470 780 1,300
Acute bronchitis 950 1,200 2,000 3,500
Asthma exacerbation 7,300 9,400 16,000 27,000
Lower respiratory symptoms 8,100 10,000 17,000 29,000
Upper respiratory symptoms 5,900 7,500 13,000 22,000
School loss days 50,000 610,000 780,000 1,300,000
Work loss days 51,000 65,000 110,000 190,000
Minor restricted activity days 430,000 2,000,000 2,700,000 4,700,000
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develop not only baseline incidence rates, but also
prevalence rates for the defining condition (e.g., asthma).
For both baseline incidence and prevalence data, age-
specific rates are preferred where available. Impact func-
tions are applied to individual age groups and then summed
over the relevant age range to provide an estimate of total
population benefits.
Estimating health benefits
Health benefits are calculated by linking the impact
function and the modeled changes in air pollution. The
change in or increment of air quality is generally deter-
mined by either a policy scenario (e.g., implementation of
SO2 emission controls at power plants) or a specific
standard or target (e.g., reduce PM2.5 levels to the annual
average standard of 15µg/m3). For policy measures for
which secondary pollutant formation (e.g., ozone, sulfate,
nitrate) and regional-scale fate and transport are relevant,
air quality changes are generally predicted using sophisti-
cated air quality models such as EPA's Community Multi-
scale Air Quality model. For primary pollutants at smaller
spatial scales, Gaussian plume models such as the Atmo-
spheric Dispersion Modeling System or more simplified
monitor rollback methods (Bell et al. 2005) can be used.
The appropriate methodology, scale, and resolution of air
quality assessment will depend on the problem context.
Analytical challenges to performing a local-scale HIA
Although national-scale HIAs in principle include local-
scale impacts, in practice, these assessments are oriented
around aggregate national impacts and are relatively less
concerned with robust characterization of subnational
impacts. Use of nationally representative impact functions
could result in large errors for any given location, which
would tend to cancel out in an aggregate assessment. Thus,
the sources of analytical uncertainty change as the scope
shifts from national-scale impacts to local-scale impacts.
The discussion below focuses on each facet of the HIA,
describes the tension between national-scale and local-scale
data, and discusses how the role of local data in the analysis
is affected by the shift in geographic scale.
In general, the tension is captured in the continuum
proposed within Fig. 2—in some cases, either limited local
data will be available or the data will be less reliable than
similar data developed at the national level (either because
of statistical power issues or because of weakness in the
study design). In those cases, the evidence used in national-
scale HIA may need to be directly applied at the local scale,
with minor modifications and an acknowledgement of how
the uncertainties change. Increasing availability of local
data may provide refined incidence/prevalence data or
insight about factors that could influence the C-R functions.
At the far end of the continuum, sufficient local data may
be available to provide site-specific epidemiological and
other local data. More detail is provided in the discussion
below for each input.
Development of appropriate C-R functions
In most cases, local-scale HIAs will need to rely on “off-
the-shelf” information available from the epidemiological
literature, given either a lack of local epidemiological
studies or the likelihood that such studies would not have
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Fig. 2 Continuum for use of
national versus local data in
local-scale HIAs. Note that a
separate continuum would
be applicable for each health
outcome
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adequate statistical power to allow the global literature to
be ignored or downweighted and preference given to the
findings of local studies. The critical question is, therefore,
whether C-R functions are transferable from the contexts in
which they were generated to a specific local-scale HIA,
given the various factors that could lead these functions to
differ by location or over time.
Although the nature of these variations will differ by
outcome and study design, the key sources of potential
heterogeneity in C-R functions between cities can be
divided into two general categories: those attributable to
differences in exposure and those attributable to differences
in potential susceptibility. Because most epidemiological
studies relate health outcomes to central-site monitored
concentrations rather than personal exposure, factors that
affect the relationship between personal exposure and
ambient concentrations can potentially affect the C-R
function. Some of these exposure-related factors include
air conditioning prevalence and utilization, availability and
effectiveness of air quality alerts, and amounts of time spent
outdoors or in traffic. Monitor siting characteristics can
also affect the magnitude and statistical significance of
estimated C-R functions as well as their interpretation and
transferability. For example, elemental carbon displays
greater spatial heterogeneity within a city than sulfates,
with potential differential effects on the degree of measure-
ment error resident in central-site monitors used to
represent community exposures to ambient PM2.5. As a
result, cities with relatively greater contributions from
secondary pollutants such as sulfate may display different
C-R functions strictly due to monitor placement. More
generally, the pollutant mixture could influence the under-
lying C-R function, related to the relative levels and
temporal profiles of ambient pollution, the chemical
composition of PM2.5, or the size distribution of PM2.5.
Susceptibility, as measured by differences in demographic
factors and baseline health across cities or across time, can
affect estimated C-R functions. The literature identifies key
factors such as age, prevalence of heart and lung disease,
education, income/poverty, access to health care, the nature
of the health care systems, and asthma prevalence. Some
recent evidence also suggests that it is important to account
for public health interventions that might modify the impacts
of air pollution on health. For example, a recent study by
Schwartz et al. (2005) found that the introduction of statin
drugs reduces the relative risk from PM2.5. The widespread
and increasing use of statin drugs in the population may
then affect the observed C-R functions for PM2.5 over
time. Careful comparisons of those exposure or suscepti-
bility factors that might change the relationship between
ambient pollutant concentrations and health outcomes
should be conducted prior to selecting C-R functions for
a particular location, as this will help determine whether
evidence is applicable directly, applicable with modifica-
tion, or inapplicable.
In general, when conducting a local-scale HIA, there
may be data from a sufficient number of cities or studies to
be able to identify factors that explain variability in C-R
functions across cities, or the literature may be inadequate
to do so. Assuming a sufficient number of candidate C-R
functions, meta-analysis and pooling techniques can be
used to develop estimates that reflect potential hetero-
geneity across cities. Standard meta-analysis or pooling
approaches involve weighting candidate studies by (for
example) the inverse of their reported variance, providing a
central estimate across the literature. An alternative to this
approach uses random rather than fixed effects, which
allows the possibility that the estimates from the different
studies may in fact be estimates of different parameters,
rather than just different estimates of a single underlying
parameter. While these simple pooling approaches can
provide better mean C-R functions for use in national-scale
HIAs, they can lead to biased results when applied to local
areas because some of the variability in C-R functions
between locations may be due to systematic factors
influencing exposure, susceptibility, or other factors. In this
case, more sophisticated meta-analysis approaches may be
required.
In recent years, several articles have been published
that involve either meta-analyses or new multicity studies
for ozone (Stieb et al. 2002; Bell et al. 2004, 2005; Ito
et al. 2005; Levy et al. 2005) and PM2.5 mortality (Levy
et al. 2000; Stieb et al. 2002; Dominici et al. 2003;
Franklin et al. 2007). In addition to developing an overall
mean C-R function, some of these studies attempted to
determine whether the C-R functions vary as a function of
co-pollutant concentrations, temperature, air conditioning
prevalence, and other factors. Among other findings,
locations with higher air conditioning prevalence appear
to have a smaller effect from ozone (Levy et al. 2005) and
PM2.5 (Franklin et al. 2007). The implication of this for
developing C-R functions for specific locations is that
national mean estimates may need to be adjusted to
account for local factors, although it should be recognized
that the covariates in metaregressions may not necessarily
be the causal factors driving the C-R functions.
In general, multicity analyses have some analytical
advantages over multistudy meta-analyses, as they impose
a consistent model specification, use the same time period
for each city included, and can be more inclusive of
locations, resulting in less chance of any publication bias.
However, if the C-R functions are strongly influenced by
model specification, single studies may be more likely to be
biased than multistudy meta-analyses that may draw on
multiple model specifications. Regardless, either type of
study can provide city-specific estimates using hierarchical
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Bayes models in which individual C-R functions for each
city represent priors for those cities, but the posterior
estimates represent a weighted average between those
observations and the results from a pooling process or
metaregression. If a city-specific estimate is highly uncer-
tain and there is either little heterogeneity in the city-
specific estimates or such heterogeneity can be explained
by defined characteristics of the cities, then less weight is
given to the city-specific observation. In contrast, if there is
significant unexplained heterogeneity and the city-specific
estimates have good statistical power, then the city-specific
estimates are given more weight. This approach recognizes
that C-R functions from cities other than the one being
evaluated within the local-scale HIA can provide insight
about the appropriate estimate for the city of interest.
For many exposures and outcomes, the literature will not
be sufficient to conduct formal metaregressions. Given the
likelihood that neither extreme on the continuum in Fig. 2
(no relevant local data or substantial and well-powered
local epidemiology) will occur, the process for determining
appropriate C-R functions for local-scale HIA in this
context requires careful development of profiles of charac-
teristics of the city of interest and study locations to find the
closest match along a range of attributes that can impact
C-R functions. Profiles can be generated using available
databases on air quality composition (obtained from the
EPAAir Quality System—http://www.epa.gov/ttn/airs/airsaqs/
or the HEI Air Quality Database—http://hei.sf.aer.com/login.
php), baseline health status (using numerous sources from
CDC), demographics (using databases from the U.S. Census
Bureau), and other factors such as climate and meteorolog-
ical variability. Formal matching analyses can be conducted
(e.g., clustering of cities based on health and air quality
attributes), or less formal approaches based on expert
analytical judgment can be used. There is no single rule
of thumb on how close areas need to be in attributes space—
to some extent, this will depend on how much uncertainty is
acceptable in the analysis. It will also depend on the attribute. If
an attribute has been shown to have a large impact on C-R
functions, then the focus should be on matching that attribute
as closely as possible. In cases where the information base
is more limited, matching may be inapplicable; in which
case, the analyst should broadly consider the degree of
uncertainty and/or bias associated with the application of the
available C-R functions.
It should be noted that the aforementioned approach is
most relevant to time-series studies, which focus on day-to-
day variations in pollution within cities. However, another
form of study is often used to examine health outcomes
associated with chronic exposures. These studies use the
variation in long-term pollution concentrations between
cities to estimate the C-R function. The best of these studies
use prospective cohort designs, which track the survival
rates (or disease-free status rates) for individuals over time,
and calculate relative risks from pollution controlling for
differences in individual-level factors such as smoking
status, diet, etc. Because these studies use between-city
variability to generate the C-R function, city-specific C-R
functions are not available. Thus, when applying the C-R
functions from cohort studies, the same estimate should be
used in each location, unless there is evidence of non-
linearities in the function. While there is some recent
evidence (e.g., Jerrett et al. 2005) that C-R functions for
cohort mortality are larger when using within-city pollution
gradients, the overall evidence is mixed, and the most
robust findings are currently based on between-city com-
parisons of PM2.5 and standardized mortality risks.
However, care should be taken to identify any systematic
differences in exposure or susceptibility between the
populations used in the cohort study and the populations
in the local-scale HIA. For example, it has been recognized
that the population studied in one of the most widely used
cohort studies, the American Cancer Society (ACS) Study
(Pope et al. 2002), is not representative of the demographic
mix in the general population. The ACS cohort is almost
entirely white and has higher income and education levels
relative to the general population. In EPA's recent expert
elicitation study, many of the experts suggested that these
sample characteristics led to a downward bias in the
estimated C-R functions relative to a C-R function that
would be representative of the general U.S. population
(Roman et al. 2008). In spite of this concern, most previous
HIA in the U.S. (U.S. EPA 2005, 2006; Levy and Spengler
2002; Levy et al. 2002) have used estimates from the
Harvard Six Cities (Laden et al. 2006) and ACS (Pope et al.
2002) studies of PM2.5-related mortality, given concerns
that other published cohort studies are less representative of
national or local populations. For example, the Washington
University-EPRI Veterans Cohort Study (Lipfert et al.
2006) involved male hypertensive veterans receiving
treatment at VA clinics, with 57% current smokers (versus
24% in the general population). Another cohort study
(McDonnell et al. 2000) focused only on nonsmoking
Seventh-Day Adventists in California. In either case, the
populations differed in demographics, risk factors, and
disease status in ways that could significantly impact the
C-R functions. As it is unlikely that any general population
HIA will exclusively capture such targeted populations, the
Six Cities and ACS study estimates will be more relevant
for local-scale HIA.
Baseline incidence/prevalence data
Unlike with C-R functions, it is likely that local baseline
incidence/prevalence data could be available for at least
some health outcomes, putting this step of the local-scale
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HIA further along the continuum in Fig. 2. In addition,
baseline incidence/prevalence may vary to a greater extent
across settings than C-R functions, implying that utilizing
baseline incidence data that are not specific to a given
location or that are not adequately geographically resolved
can introduce important uncertainties to the analysis. For
example, ZIP code-level asthma hospitalization rates vary
substantially within Detroit, ranging from a minimum of 10
to a maximum of 129 per 10,000 (Fig. 3). In contrast, EPA
has used a single estimate of 28 in 10,000 in its national-
scale RIAs (U.S. EPA 2005, 2006).
The implications of using spatially resolved local
baseline incidence rates become clear when estimating the
changes in asthma-related hospital admissions resulting
from a hypothetical 20% reduction in PM2.5 levels in
Detroit (Fig. 3). Using the EPA default baseline hospital-
ization rate generates a total reduction in asthma-related
hospitalizations of 36 cases (90%CI=17, 54). In contrast,
using the local-scale rates produces a reduction in asthma-
related hospitalizations of 53 cases (90%CI=26, 81).
Clearly, using default baseline incidence rates would
underestimate the total change in this particular health
endpoint in Detroit and would not capture the spatial and
demographic variability in that endpoint.
The chief impediment to using high-resolution baseline
incidence data is that it is very resource-intensive to
produce or may not be available for the outcome of interest
with sufficient coverage within a given urban area. For the
Detroit example, while the Michigan Department of
Environmental Quality (Wasilevich 2005) furnished U.S.
EPA with estimates of baseline incidence rates for many
key PM2.5-related health endpoints, such as nonfatal heart
attacks and chronic bronchitis, small ZIP code-level
population sizes triggered data suppression rules, resulting
in omitted incidence estimates for a number of locations
within the city. Moreover, while the department maintains a
comprehensive asthma epidemiology database which pro-
vides good spatial coverage of Detroit, it was still necessary
for an epidemiologist to reformat these data to generate
tables in a format suitable for use in an HIA. The EPHT
program may serve a valuable role by providing technical
guidance to localities as they consider collecting such data.
Given these constraints, local-scale baseline incidence
rates for each health endpoint of concern will not always be
available. However, rather than relying solely on national or
broad regional estimates, it may be possible to apply
interpolation or other estimation techniques to infer the
baseline rates for the city—or perhaps for certain locations
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Fig. 3 Comparison of the geographic distribution of ZIP code-level asthma hospitalization rates and a hypothetical 20% reduction in monitored
PM2.5 in the Detroit metropolitan area
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within a city—of interest. For example, if incidence rates
correlate well with some number of easily observed
independent variables—perhaps age, race, and geographic
region—then one could estimate the baseline incidence
rate. This approach has been followed previously, as
baseline incidence data were simulated at high resolution
as a function of demographic factors (Levy et al. 2002). A
limitation is the fact that this relies heavily on the
assumption that factors such as race and education are
universally applicable causal factors rather than covariates
reflecting complex contextual relationships within the
underlying studies from which the correlations were
developed. Geostatistical interpolation techniques, such as
kriging and co-kriging, may also be of some use in creating
a spatial surface of interpolated baseline incidence rates.
The uncertainty these methods introduce, though signifi-
cant, is likely outweighed by the improved representation
of geographic heterogeneity inherent in baseline incidence
rates.
Air quality data
Changes in air quality—monitored or modeled—ultimately
drive estimates of health impacts. A key analytical
challenge is to represent both the spatial distribution and
scale of these air quality changes, an issue of particular
significance for local-scale HIA, for which more finely
resolved estimates of air quality changes may take on added
importance. For pollutants such as directly emitted PM2.5,
we would expect a high degree of variability in the geo-
graphic distribution of air quality changes across urban
areas, given certain source controls. For example, evidence
suggests that directly emitted particles from motor vehicles
(Roorda-Knape et al. 1998; Zhu et al. 2002) or point
sources such as metal processors and glass manufacturers
(U.S. EPA 2006) have a pronounced spatial gradient as a
function of distance from the source. However, for HIA, the
impact of these emissions on total population exposure is
more relevant than the concentration profile itself, and
some studies have shown a much larger spatial extent of
impact even for primary PM2.5 when considered from a
total population exposure perspective (Greco et al. 2007).
Local-scale HIA for PM2.5 and ozone are further compli-
cated by the importance of secondary formation, which
implies that sources outside of the geographic area of
interest will influence local air quality and that sources
inside the area of interest will influence public health at a
regional or national scale.
Without knowing the policy context for the local-scale
HIA, it is difficult to know the extent to which monitors or
models can be used or the necessary scale and resolution.
One general statement that can be made is that the
estimated changes in air quality must be reasonably in
agreement with the way in which exposure was character-
ized within the epidemiological studies used to derive C-R
functions. If the C-R function is derived from a single
central-site monitor, highly spatially resolved exposure
characterization would be more difficult to interpret within
an HIA. That being said, finer-scale air quality data will
clearly take on added importance for a local-scale HIA in
which it may be of interest to align inputs such as the
baseline incidence rates and populations with the spatial air
quality gradient.
Comparing locally developed health impact estimates
with literature-based estimates
In many cases, even if analysts conduct a local-scale HIA
using locally generated baseline incidence and prevalence
rates, C-R functions, and air quality estimates, it may be
useful to generate health impacts using literature-based
estimates as well as a way of putting the local data-based
estimates into context. In comparing these estimates, it will
be important to understand what differences might be
expected versus differences that cannot be expected or
explained. In addition to evaluating differences between
attributes of locations, analysts should also be aware of the
timeframe in which a national analysis was conducted.
Some population or air quality characteristics may have
changed significantly between the time when a study was
conducted and the present, as discussed in more detail
below.
In addition to local area attributes, analysts should also
compare the statistical methodologies used in generating
the local area estimates relative to those used in generating
the literature-based estimates. For example, if different
functional forms are used for a local epidemiological study
and the published literature (e.g., 2-day moving average
versus distributed lags), then differences in the results
would be expected, solely from the statistical methods used.
Similarly, data collection and aggregation methods may
differ for baseline incidence/prevalence data.
Consideration of time-varying factors in conducting
local-scale health impact assessments over time
As noted above, population and air quality attributes will
likely change over time, making interpretation of the
outputs of local-scale HIAs over time challenging. From
an accountability perspective, if these changes are not
accounted for, then the “signal” from programs intended to
reduced air pollution-related health risks can be masked or
overstated. For example, if the age composition of a
population is becoming older over time, but air quality
and other factors are unchanged, the population health risks
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will appear to increase over time simply because the “at
risk” susceptible proportion of the population is increasing.
While these demographic changes should clearly be
incorporated, the resulting HIAs could be misleading if
not interpreted carefully.
Some time-varying factors that should be considered
when designing a multiple year assessment program
include demographics, exposure modifiers, air pollution
sources, pollutant composition, and meteorology/climate.
Demographic factors may include age composition, race,
educational levels, income and income disparity, and
population health characteristics such as rates of obesity,
asthma, and heart disease. This includes covariates that
could explain between-city variability in C-R functions or
baseline incidence rates, so the process of determining the
appropriate impact functions for a local-scale HIA can help
to elucidate the most significant time-varying factors to
consider.
Changes over time in the composition of air pollution
could influence local atmospheric chemistry, leading to
increased or decreased formation of secondary PM2.5 or
ozone for a given amount of emissions controls and could
potentially influence the toxicity of the pollutant mixture.
These changes may occur both due to pollution control
programs and due to natural economic factors such as plant
closures. Finally, as climate changes over time, both the
susceptibility of populations to air pollution and the nature
of air pollution events may change. Higher temperatures
may increase susceptibility to air pollution-related health
effects across the U.S., changing C-R functions (Roberts
2004). Several recent studies have found an increased risk
of air pollution stagnation events under projected changes
in the global and regional climate, which are expected to
decrease cyclone frequencies throughout the U.S. (Leung
and Gustafson 2005; Mickley et al. 2005; Wu et al. 2007).
Forward-looking design of HIA protocols can help to
avoid comparability problems by including explicit con-
sideration of time-varying factors. With the proper study
design, as conditions change, the changes in effects
expected from air pollution reductions can be isolated from
changes in effects due to other time-varying factors.
Characterizing uncertainty in local-scale health
impact assessments
An important component of any HIA is a characterization
of the uncertainties associated with estimates of health
impacts. While techniques exist to provide probabilistic
estimates of impacts, those techniques are limited by a lack
of input data on uncertainty in individual impact function
elements. For some elements, such as the C-R function,
there is at least some limited information on uncertainty, in
the form of standard errors from the statistical estimation,
while for others, e.g., baseline incidence rates, there is no
information available. Bayesian approaches, such as hier-
archical Bayes analyses used in multicity epidemiological
studies, can provide additional characterization of uncer-
tainty because they partially account for heterogeneity
between cities, thus accounting for some of the uncertainty
about transferability. However, even these approaches
cannot address overall model uncertainty or uncertainty
about causality.
As alluded to earlier, one approach that has been utilized
in a limited number of settings involves formal expert
elicitation. The U.S. EPA recently conducted an expert
elicitation to try to provide a more complete assessment of
the uncertainties associated with the C-R function for
PM2.5-related mortality (Roman et al. 2008). Expert
elicitation is useful in integrating the many sources of
information about uncertainty in the C-R function because
it allows experts to synthesize these data sources using their
own mental models and provide a probabilistic representa-
tion of their synthesis of the data in the form of a
probability distribution of the C-R function. The goal of
the study was to elicit from a sample of health experts
probabilistic distributions describing uncertainty in esti-
mates of the reduction in mortality among the adult U.S.
population resulting from reductions in ambient annual
average PM2.5 levels. Expert elicitation methods are still
somewhat controversial, and care should be taken to follow
formal expert elicitation protocols. It is also unlikely that
expert elicitations at this scale would be conducted for
an individual local-scale HIA, or even for many of the
key elements, given the cost, time, and lack of empirical
data from which experts could derive informed opinions.
However, results from available expert elicitations can
provide a more robust understanding of uncertainties in
different analytical components and may eventually provide
insight about some of the transferability concerns central in
local-scale HIA.
There are some types of uncertainties that are especially
important when conducting a local-scale HIA using
national-scale data or transferring data from a different
location. These uncertainties relate to the factors identified
in the sections above on choosing C-R functions. These
uncertainties can be minimized (but not eliminated) by
careful selection of C-R functions based on cities that are
similar to the city under analysis. Other sources of
uncertainty at the local scale include uncertainty in the
application of regional-average or national-average baseline
incidence rates and uncertainty in changes in air quality at
fine spatial resolution or for specific populations. These
uncertainties can be minimized by using as spatially refined
estimates as available. While many of these uncertainties
may be difficult to quantify, sensitivity analyses can be
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conducted to examine individual assumptions or combina-
tions of assumptions. When communicating the results of
sensitivity analyses, care should be taken to indicate the
potential likelihood of the set of assumptions to avoid
giving an artificially distorted impression of the likely range
of impacts.
Conclusions and recommendations
Properly conducted local-scale HIAs can be informative
and defensible. However, there are many opportunities for
biases and uncertainties to be introduced into the analytical
process and the findings. Careful attention to the inputs to
the analysis can help to minimize uncertainties and reduce
the potential for biased results. In addition, comparison
with results from other locations or with national-scale
results can provide context for the results and a check on
the reasonableness of estimates.
Some key recommendations for conducting interpretable
local-scale HIAs include:
& Clearly identify characteristics of study locations that
may influence health impact estimates, including major
emission sources, air quality composition, population
demographics (age, race, income, etc.), and climate/
meteorology. When applying previously published
epidemiological studies, pay attention to statistical
designs, including functional forms, controls for weather
and other confounders, lag structures, treatment of
missing values, and timeframes for each study from
which a C-R function is derived.
& Where available, use city-specific estimates derived
from multicity studies, which ideally use Bayesian
methods to leverage findings from all cities. In these
cases, use meta-analytic techniques to formally evaluate
factors contributing to between-city variability in C-R
functions and to determine appropriate local-scale
estimates. If there are no multicity studies or sufficient
studies for a meta-analysis, compare characteristics in
the local area to the characteristics of the source study
locations and select C-R functions from studies or cities
with characteristics closely matching those of the local
area to the extent possible.
& Choose a spatial resolution for estimation of changes in
air quality appropriate given the exposure assessment
within the epidemiological studies of interest, the spatial
gradient in air pollution given the pollutant and sources
being controlled within the assessment, and potential for
correlation with population demographics. In cases where
there is a sharp gradient in air pollution that is highly
correlated with spatial gradients in population density or
susceptibility characteristics, high-resolution data should
be used in spite of the attendant uncertainties and potential
issues in combining these data with epidemiological
evidence based on central-site monitors.
& Baseline health outcome data should be as spatially and
demographically refined as possible. When local base-
line health data are not available, analysts should
consider using prediction or interpolation methods to
derive local baseline rates using national or regional
estimates coupled with locally available data shown to
be correlated with the health outcomes of interest.
& Design multiyear HIA studies with accountability and
comparability in mind. Designs should incorporate
time-varying factors, including baseline population
health (which may be influenced by the availability of
certain types of medical interventions like statin drug use),
socioeconomic factors, climate (e.g., mean summer
temperatures), sources of emissions (which can affect the
composition of local air pollution), and availability of
detailed air quality forecasts, that can influence the
relationship between air pollution and health.
& Uncertainty should be discussed and characterized
quantitatively where possible. Probabilistic approaches
can be used to characterize some uncertainties, but
should be accompanied by single-attribute and multi-
attribute sensitivity analyses to address uncertainties
that do not have good probabilistic data available.
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